赛托生物(300583) - 2025 Q4 - 年度业绩预告
Sito BioSito Bio(SZ:300583)2026-01-30 08:00

Financial Performance - The company expects a net profit loss between 63 million to 88 million CNY for the year 2025, compared to a loss of 88.77 million CNY in the same period last year[5] - The net profit loss after deducting non-recurring gains and losses is projected to be between 66 million to 91 million CNY, compared to a loss of 103.36 million CNY in the previous year[5] Reasons for Performance Decline - The primary reasons for the performance decline include a decrease in product market prices leading to a lower overall gross margin and reduced profits[7] - The company has increased its R&D investment during the reporting period, contributing to the decrease in net profit[7] - Significant inventory impairment provisions were made for several intermediate products due to price declines, impacting current profits[7] Financial Reporting - The financial data presented is preliminary and has not been audited by the accounting firm, with further details to be disclosed in the 2025 annual report[8]

Sito Bio-赛托生物(300583) - 2025 Q4 - 年度业绩预告 - Reportify